Neuronetics, Inc.

NASDAQ:STIM

Medical - Diagnostics & Research

Healthcare
$1.24 +0.31%

+$0.00 today

Market cap
$96.38M
Beta
1.04
P/E (TTM)
-2.3
EPS (TTM)
-$0.53
52W Low $0.80High $4.85

Volume 1.66M

Average 2.44M

Returns on capital

Neuronetics, Inc. management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management
Older years hidden. Sign in to unlock

ROE

-174.3%

avg -71.0%

ROIC

-27.0%

avg -34.1%

ROA

-27.6%

avg -31.0%

Analysis

ROIC is currently the strongest return metric at -27.0% versus its period average of -34.1%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

Daniel L. Reuvers

President, Chief Executive Officer & DirectorUSD 927.61K630<0.01%

Cory S. Anderson

Executive Vice President & General Manager of Greenbrook—49——

Nir Naor

Executive VP, CFO, Corporate Secretary, Principal Financial and Accounting Officer & Treasurer—510<0.01%

Robert Greene

Senior Vice President of Sales————

Compensation is shown in the reported currency; data updated Nov 7, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Jul 23, 2026.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

Buys

16

$4.93M

Sells

17

$4.76M

Net Transaction Value

+$169,175.53

Net buying

Most Active

Chernett Jorey

22 transactions

Transactions sorted by date, descending.

Open-market insider purchases and sales reported during the last 12 months
Type
Nov 13, 26

Chernett Jorey

Direct

Sell$2.5M
Nov 12, 26

Chernett Jorey

Direct

Sell$1M
Nov 11, 26

Chernett Jorey

Direct

Sell$139.7K
Nov 9, 26

Chernett Jorey

Direct

Sell$214.2K
Nov 9, 26

Chernett Jorey

Direct

Buy$79.6K
Nov 6, 26

Chernett Jorey

Direct

Sell$599.4K
Oct 30, 26

Chernett Jorey

Direct

Buy$40.9K
Aug 14, 26

Chernett Jorey

Direct

Buy$44.2K
Aug 13, 26

Chernett Jorey

Direct

Sell$500
Jul 14, 26

Chernett Jorey

Direct

Buy$62.3K

1–10 of 33

Summary

Insiders reported 16 buys worth $4.93M and 17 sells worth $4.76M over the last 12 months. That adds up to net buying of $169,175.53. Chernett Jorey was the most active insider with 22 transactions.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A1 analysts
RevenueN/AN/A+31.8%
+9.0% (5yr)2 analysts
Net IncomeN/AN/AN/A
N/A2 analysts
EBITN/AN/AN/A
N/A2 analysts

Analysis

Recent growth has been strongest in Revenue at +31.8% over three years. Forward estimates point to Revenue at +9.0% (5yr), giving you a quick check on whether expectations are accelerating or cooling.

Competitors

Who does Neuronetics, Inc. compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about STIM's management, answered from reported figures.

Who manages STIM?

Neuronetics, Inc. (STIM) lists 4 active executives. The top listed executive is Cory S. Anderson, Executive Vice President & General Manager of Greenbrook.

Are STIM insiders buying or selling?

Recent insider activity shows net selling of $14.59M.